血清TG/HDLC与SPP24对血液透析患者发生心血管事件的预测效能

doi:10.3760/cma.j.issn.1007-1245.2024.06.017

摘要/Abstract

摘要：

目的　分析血清三酰甘油/高密度脂蛋白胆固醇（TG/HDLC）、分泌型磷蛋白24（SPP24）对血液透析患者心血管事件发生的预测效能。方法　前瞻性选取2020年6月至2022年6月长安医院收治的159例行维持性血液透析患者，其中男88例，女71例，年龄>18岁，随访患者1年期间心血管事件发生情况，将出现心血管事件的41例患者纳入心血管事件组，未出现心血管事件的118例患者纳入非心血管事件组。检测患者血清TG/HDLC、SPP24水平。采用t检验、χ²检验、logistic回归分析模型分析影响维持性血液透析患者心血管事件发生的因素，采用受试者操作特征曲线（ROC）分析血清TG/HDLC、SPP24预测维持性血液透析患者心血管事件发生的效能。结果　多因素logistic回归分析显示，透析龄（OR=4.586，95%CI 1.887～11.145）、TG/HDLC（OR=3.904，95%CI 1.594～9.563）、SPP24水平（OR=0.308，95%CI 0.127～0.748）是影响维持性血液透析患者心血管事件发生的影响因素（均P<0.05）。ROC分析结果显示，TG/HDLC、SPP24及二者联合预测维持性血液透析患者发生心血管事件的灵敏度分别为70.73%（95%CI 54.26%～83.35%）、68.29%（95%CI 51.78%～81.42%）、82.93%（95%CI 67.35%～92.30%），特异度分别为70.34%（95%CI 61.12%～78.21%）、75.42%（95%CI 66.48%～82.68%）、89.83%（95%CI 82.56%～94.40%），曲线下面积（AUC）分别为0.733（95%CI 0.638～0.828）、0.708（95%CI 0.597～0.819）、0.894（95%CI 0.829～0.959）。结论　血清TG/HDLC联合SPP24可提高对维持性血液透析患者心血管事件发生的预测效能。

关键词:

血液透析, 心血管事件, 三酰甘油/高密度脂蛋白胆固醇, 分泌型磷蛋白24, 效能

Abstract:

Objective　To explore the efficacy of serum triglyceride/high density lipoprotein cholesterol (TG/HDLC) and secreted phosphoprotein 24 (SPP24) in predicting cardiovascular events in hemodialysis patients. Methods　A total of 159 patients undergoing maintenance hemodialysis admitted to Chang An Hospital from June 2020 to June 2022 were prospectively selected, including 88 males and 71 females, aged >18 years, and cardiovascular events were followed up for 1 year. Forty-one patients with cardiovascular events were included in the cardiovascular event group, and 118 patients without cardiovascular events were included in the non-cardiovascular event group. Serum TG/HDLC and SPP24 levels were detected. t test, χ² test, and logistic regression analysis model were used to analyze the factors affecting the occurrence of cardiovascular events in maintenance hemodialysis patients. Receiver operating characteristic curve (ROC) was used to analyze the efficacy of serum TG/HDLC and SPP24 in predicting cardiovascular events in maintenance hemodialysis patients. Results　Multivariate logistic regression analysis showed that dialysis age (OR=4.586, 95%CI 1.887-11.145), TG/HDLC (OR=3.904, 95%CI 1.594-9.563), and SPP24 level (OR=0.308, 95%CI 0.127-0.748) were the influencing factors for cardiovascular events in maintenance hemodialysis patients (all P<0.05). ROC analysis results showed that the sensitivities of TG/HDLC, SPP24, and their combination in predicting cardiovascular events in maintenance hemodialysis patients were 70.73% (95%CI 54.26%-83.35%), 68.29% (95%CI 51.78%-81.42%), and 82.93% (95%CI 67.35%-92.30%), respectively, the specificities were 70.34% (95%CI 61.12%-78.21%), 75.42% (95%CI 66.48%-82.68%), and 89.83% (95%CI 82.56%-94.40%), respectively, and the areas under the curves were 0.733 (95%CI 0.638-0.828), 0.708 (95%CI 0.597-0.819), and 0.894 (95%CI 0.829-0.959), respectively. Conclusion　Serum TG/HDLC combined with SPP24 can improve the predictive efficacy of cardiovascular events in maintenance hemodialysis patients.

Key words:

Hemodialysis, Cardiovascular events, Triglyceride/high density lipoprotein cholesterol, Secreted phosphoprotein 24, Efficiency

杜琳李文娟朱咏梅.

血清TG/HDLC与SPP24对血液透析患者发生心血管事件的预测效能 [J]. 国际医药卫生导报, 2024, 30(6): 963-967.

Du Lin, Li Wenjuan, Zhu Yongmei.

Predictive efficacy of serum TG/HDLC and SPP24 for cardiovascular events in hemodialysis patients [J]. International Medicine and Health Guidance News, 2024, 30(6): 963-967.

参考文献

[1] Campbell RE, Thurman JM. The immune system and idiopathic nephrotic syndrome[J]. Clin J Am Soc Nephrol, 2022,17(12):1823-1834.DOI: 10.2215/CJN.07180622.
[2] Rodriguez-Ballestas E, Reid-Adam J. Nephrotic syndrome[J]. Pediatr Rev, 2022,43(2):87-99.DOI: 10.1542/pir.2020-001230.
[3] 李小会,陈丽名,屈杰. «伤寒论»寒热并用法在慢性肾脏疾病治疗中的应用[J]. 西部中医药,2023,36(11):65-68. DOI:10.12174/j.issn.2096-9600.2023.11.14.
[4] Gould DW, Doidge J, Sadique MZ,et al. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study[J]. Health Technol Assess, 2022 ,26(13):1-58.DOI: 10.3310/ZXHI9396.
[5] Warnar C, Faber E, Katinakis PA,et al. Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy[J]. J Clin Monit Comput, 2022,36(3):871-877.DOI: 10.1007/s10877-021-00719-8.
[6] 莫怡浩,王丽,胡明亮,等. 尿毒症维持性血液透析患者外周血NLRP3、IL-1β、IL-18水平与血管钙化的相关性分析[J]. 中国中西医结合肾病杂志,2023,24(5):398-400. DOI:10.3969/j.issn.1009-587X.2023.05.008.
[7] 汪红平,王超凡,高洁,等. 三酰甘油葡萄糖乘积指数及三酰甘油高密度脂蛋白胆固醇比值对初发急性心肌梗死患者近期预后的影响[J]. 中国糖尿病杂志,2022,30(11):835-842. DOI:10.3969/j.issn.1006-6187.2022.11.008.
[8] Rathi H, Kumar R, Goyal B,et al. Assessment of dyslipidemia, lipid ratios, and atherogenic indices as cardiovascular risk factors in prediabetic and diabetic subjects[J]. J Lab Physicians, 2022,14(4):420-426.DOI: 10.1055/s-0042-1744240.
[9] 王雪荣,许雯婷,包婷,等. 分泌型磷蛋白24与维持性血液透析患者心脏瓣膜钙化及心血管事件的相关性研究[J]. 安徽医科大学学报,2022,57(7):1156-1160. DOI:10.19405/j.cnki.issn1000-1492.2022.07.027.
[10] 张一页,鄢艳. 血液透析患者自体动静脉内瘘临床预测模型研究现状概述[J]. 中国血液净化,2023,22(3):198-201. DOI:10.3969/j.issn.1671-4091.2023.03.009.
[11] 中国中西医结合学会肾脏疾病专业委员会. 慢性肾衰竭中西医结合诊疗指南[J]. 河北中医,2016,38(2):313-317. DOI:10.3969/j.issn.1002-2619.2016.02.049.
[12] 何伋.实用临床心脑血管病学[M].长春:吉林科学技术出版社, 2014: 96-97.
[13] Anantharaman S, Chionh CY. Correcting hyponatremia by fluid sodium modulation in continuous renal replacement therapy with regional citrate anticoagulation[J]. Semin Dial, 2022,35(2):198-203.DOI: 10.1111/sdi.13054.
[14] 刘妍,陈洪娇,张娜,等.区域协同救治体系对急性ST段抬高型心肌梗死救治效率及预后影响的Meta分析[J].中国急救复苏与灾害医学杂志,2024,19(1):8-15.
[15] 陈润都,孟凡鹏,张梅. 游泳训练对血压、血脂等心血管疾病危险因素影响的Meta分析[J]. 武警医学,2020,31(1):1-4,8. DOI:10.3969/j.issn.1004-3594.2020.01.001.
[16] 岑锦明,杨希立,许兆延,等. iMapTM血管内超声检测冠状动脉粥样斑块坏死核心与心血管疾病危险因素、Lp-PLA2相关性[J]. 介入放射学杂志,2018,27(12):1134-1139. DOI:10.3969/j.issn.1008-794X.2018.12.004.
[17] Agarwal R, Filippatos G, Pitt B,et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis[J]. Eur Heart J, 2022,43(6):474-484.DOI: 10.1093/eurheartj/ehab777.
[18] 王亚卿,刘晓红. 非对称二甲基精氨酸、N-单甲基左旋精氨酸与慢性肾脏疾病并发心血管疾病关系的研究进展[J]. 中西医结合心脑血管病杂志,2021,19(1):84-86. DOI:10.12102/j.issn.1672-1349.2021.01.019.
[19] 曾鹏廷. FGF23、klotho在慢性肾脏病患者心血管疾病中的作用[J]. 重庆医学,2017,46(5):697-700. DOI:10.3969/j.issn.1671-8348.2017.05.040.
[20] Evans M, Lewis RD, Morgan AR,et al. A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives[J]. Adv Ther, 2022 ,39(1):33-43. DOI: 10.1007/s12325-021-01927-z.
[21] Li X, Lindholm B. Cardiovascular risk prediction in chronic kidney disease[J]. Am J Nephrol, 2022,53(10):730-739. DOI: 10.1159/000528560.
[22] 陈利明,刘亚玲,李雪,等. 18F-NaF PET/CT显像评估维持性血液透析患者血管钙化的作用[J]. 临床放射学杂志,2023,42(11):1830-1837.
[23] 高爽,叶盛梅,佟瑞华. 血液灌流联合血液透析对尿毒症性皮肤瘙痒患者钙磷代谢、炎症指标及生活质量的影响[J]. 中国临床医生杂志,2023,51(7):820-823. DOI:10.3969/j.issn.2095-8552.2023.07.018.
[24] 李娟,吴邯,刘芳,等. 基于健商评估的分级营养干预对终末期肾病维持性血液透析患者营养参数及磷钙达标率的影响[J]. 中国医药导报,2023,20(14):175-178. DOI:10.20047/j.issn1673-7210.2023.14.38.
[25] 陈东,蒋知新,张洁,等. 血清骨硬化蛋白、成纤维细胞因子-23、可溶性CD40配体联合检测对维持性血液透析并发心血管事件的预测价值[J]. 安徽医药,2023,27(2):291-296. DOI:10.3969/j.issn.1009-6469.2023.02.018.
[26] 高菊,范英姿,欧小琳. 维持性血液透析患者血清ADAMTS13、Sema3A水平与主要不良心血管事件发生的关系[J]. 山东医药,2022,62(34):6-10. DOI:10.3969/j.issn.1002-266X.2022.34.002.
[27] Rathi H, Kumar R, Goyal B,et al. Assessment of dyslipidemia, lipid ratios, and atherogenic indices as cardiovascular risk factors in prediabetic and diabetic subjects[J]. J Lab Physicians, 2022 ,14(4):420-426. DOI: 10.1055/s-0042-1744240.
[28] Brochmann EJ, Simon RJ, Jawien J,et al. Carboxy terminus of secreted phosphoprotein-24 kDa (spp24) is essential for full inhibition of BMP-2 activity[J]. J Orthop Res, 2010,28(9):1200-1207.DOI: 10.1002/jor.21102.
[29] Turner ME, White CA, Taylor SM,et al. Secreted phosphoprotein 24 is a biomarker of mineral metabolism[J]. Calcif Tissue Int, 2021 ,108(3):354-363. DOI: 10.1007/s00223-020-00783-3.
[30] Guan H, Zhang J, Luan J,et al. Secreted frizzled related proteins in cardiovascular and metabolic diseases[J]. Front Endocrinol (Lausanne), 2021,12:712217. DOI: 10.3389/fendo.2021.712217.